How do you start a mobile IV therapy clinic in 2027?

The two structural paths: solo RN concierge versus fleet, franchise, or platform

Every founder who asks how to start a mobile IV clinic is really choosing between five delivery structures, and the choice locks in your capital, your margin ceiling, and your compliance burden for the next three years. They are not interchangeable. Picking the wrong one early is the single most expensive reversible mistake in this business, because unwinding a franchise agreement or a brick-and-mortar lease costs far more than the extra month of diligence would have.

Solo RN concierge. You are the injector, the scheduler, the marketer, and the bookkeeper. There are no employees in year one, maybe a 1099 backup nurse for overflow weekends. Your vehicle is your personal car with an optional wrap. Your inventory sits in a locked, temperature-controlled tote in a spare room. This is the dominant format by a wide margin — the large majority of active US operators are solo or two-to-three-nurse micro-practices serving a single metro. Capital lands in the $45,000 to $185,000 range, and the gating constraint on revenue is your own calendar: you cannot serve more patients than you can physically drive to and cannulate in a day.

Two-to-three RN fleet. The founder steps out of the bag-administration role and into dispatch, sales, and medical-director management. This is the hardest transition in the whole progression, harder than the initial launch, because it converts a clinical job into a management job overnight and most clinically trained founders hate the swap. You now carry payroll or contractor liability, a real dispatch system, multiple vehicles, and a marketing budget that has to generate demand for other people's hands, not just your own. Capital runs $185,000 to $485,000.

Franchise. You buy brand, playbooks, group purchasing on bags and supplies, and — genuinely valuable — a compliance department that has already fought the state-board fights in your market. You pay a franchise fee up front, an ongoing royalty on gross revenue, and a marketing fund contribution. You accept territory restrictions and a transfer-approval requirement on exit. The trade is autonomy and margin for de-risked speed.

Drip-bar hybrid. A fixed retail location with reclining infusion chairs plus mobile dispatch capability. Roughly 1,200 to 2,800 square feet, medical-grade flooring, a sink, secure storage, reception and waiting. You gain walk-in volume, retail supplement sales, and a physical trust signal that converts skeptical first-timers. You lose the entire structural cost advantage of mobile — you now have rent whether anyone books or not. Capital typically $285,000 to $685,000.

Platform partnership. Companies like Hydreight Technologies (publicly traded on the TSX-V as HYDQ) run a platform-as-a-service model: nurses join a managed network with central compliance, medical director coverage, scheduling, payment processing, and insurance, and the platform takes a revenue share. Launch time compresses from months to weeks. Per-session economics compress too. It is the lowest-capital, lowest-autonomy entry point, and it is a legitimate way to test a market before committing to your own entity.

The adjacent-format question matters as much as the format question. A mobile IV clinic sits near a med spa (cosmetic anchor, tighter corporate-practice-of-medicine rules, heavier build-out), a direct primary care practice (membership-funded primary care, no injectables focus), a hospital-affiliated infusion center (insurance-billed, medically necessary infusion, an entirely different regulatory animal), and a functional medicine clinic (broader integrative practice where IV is one adjunct among many). Founders regularly start down the mobile IV road and discover eighteen months in that what they actually wanted was one of the neighbors. Mobile IV is specifically the cash-pay, wellness-positioned, nurse-delivered, low-overhead, location-flexible end of that spectrum. If you want insurance revenue, this is the wrong model. If you want to own a building, this is the wrong model. If you want to be somewhere different every day and keep fixed costs near zero, this is exactly it.

How to decide between them

The decision tree is shorter than founders expect, because two inputs — your state's scope-of-practice regime and whether you personally hold an RN or NP license — eliminate most branches before capital even enters the conversation.

Start with state scope. Every US state permits a registered nurse to administer IV therapy under a physician's order. What varies enormously is how you obtain that order and how much physician involvement the state demands on an ongoing basis. Permissive states — Florida, Texas, Arizona, Colorado, Nevada, Georgia, Tennessee, and North Carolina among them — generally let an RN work under a written collaborative practice agreement with a collaborating physician, using standing orders that cover pre-defined protocols, with periodic chart review and physician availability for consultation. The valid physician examination establishing the patient relationship can often happen by telehealth. Stricter states — California, New York, New Jersey, Massachusetts, Illinois, and Pennsylvania are the commonly cited ones — expect an employed or contracted MD/DO medical director, a documented patient examination before standing orders take effect, and in some cases in-person evaluation for a first visit. Ohio, Michigan, Washington, and Oregon sit between the two models with state-specific wrinkles.

That single variable moves your monthly compliance cost by thousands of dollars and moves your launch timeline by months. It also determines whether you can realistically be a solo operator at all. Do not take a blog post's word for your state's posture, including this one — the boards issue interpretive guidance and cease-and-desist actions that never make it into general-audience summaries. Retain healthcare regulatory counsel with med spa and mobile IV experience before you spend a dollar on inventory. A few thousand dollars of legal opinion up front is dramatically cheaper than a board complaint two years in, and the firms that specialize here have seen every variation of your question.

Second input: do you hold the clinical license yourself? An RN or NP founder can be the entire clinical delivery mechanism on day one, which is what makes the sub-$100,000 launch possible. A non-clinical founder must hire clinical labor before generating a single dollar of revenue, which pushes the realistic capital floor up substantially and changes the risk profile — you are now paying wages during the demand-discovery phase, which is precisely when demand is least predictable. Non-clinical founders should weight the platform-partnership and franchise options much more heavily, because both supply clinical infrastructure you would otherwise build alone. Many states also restrict who may own a professional entity that delivers medical services, which is another reason the ownership question routes straight to counsel rather than to a formation website.

Third input: your realistic 24-month time commitment. A solo route is a full-time clinical job with an administrative job stapled to the evenings. A fleet is a management job. A franchise is a management job with homework. Founders who want passive income from mobile IV are almost universally disappointed, because the model's margin comes from low fixed cost, not from operating leverage — and low fixed cost means you, personally, absorbing the work.

The concrete numbers behind each option

Capital, revenue, and margin behave differently enough across formats that generic startup-cost figures are close to useless. Here is what actually sits inside each number.

Solo RN concierge line items. Entity formation and registered agent, a few hundred dollars. Healthcare regulatory counsel for scope review, entity structure, and template consent and CPA documents — this is where founders under-budget, and it is worth several thousand dollars done properly. Medical director or collaborating physician retainer, running roughly $1,000 to $3,000 monthly in permissive states and materially higher where an employed director is required. Starting bag and supply inventory of $4,000 to $12,000. IV cart, poles, start kits, sharps containers, a blood pressure cuff, pulse oximeter, thermometer, and emergency anaphylaxis kit, $3,000 to $15,000. Vehicle wrap, $1,500 to $4,000 if you want one. Nurse malpractice coverage, roughly $1,500 to $4,000 per nurse annually for standard occurrence-based limits. Commercial auto, $1,800 to $3,600. General liability and cyber coverage on top. HIPAA-compliant scheduling and charting software, somewhere between $30 and $200 monthly depending on platform. Payment processing at standard card-present rates. Launch marketing, $2,000 to $8,000 monthly.

Revenue mechanics. Session pricing spans a wide band by market and SKU complexity. Standard hydration and vitamin bags commonly run $150 to $285. Beauty and skin-oriented bags price higher. NAD+ infusions carry a large premium because of both ingredient cost and infusion time — a single session ties up one to four hours of nurse capacity, which is the real constraint. Multi-day NAD+ protocols are sold as packages. Intramuscular add-ons — B12, B-complex, glutathione push, magnesium — run $35 to $185 each and are the single most reliable margin lever available, because they add revenue without adding travel time.

That last point deserves emphasis, because it is the economic heart of the model. Your scarce resource is not capital or inventory. It is the nurse-hour, and specifically the drive-time-inclusive nurse-hour. A route serving four to eight patients per day at a $185 to $385 average ticket produces roughly $1,200 to $2,800 of revenue per route-day. Working 18 to 22 route-days monthly, a solo nurse generates something in the $22,000 to $58,000 monthly range early and $35,000 to $95,000 at a mature route with strong B2B contracts and a membership base. Every add-on injectable sold to a patient you already drove to is nearly pure incremental margin. Every minute of unnecessary drive time is pure loss.

Cost structure at maturity. Cost of goods — bags, compounded ingredients, disposables — typically runs 22 to 38 percent of revenue depending on SKU mix, with standard bags carrying the best gross margins and NAD+ the worst by percentage despite the highest absolute dollars. Clinical labor runs 25 to 42 percent depending on classification and ticket size. Vehicle, insurance, software, payment processing, and marketing consume 18 to 28 percent. What survives is roughly 22 to 38 percent net operating margin before owner compensation at a stabilized solo route.

Where the fleet math diverges. Adding nurses does not multiply that margin. It compresses it, typically into the high teens to low thirties, because you have added supervision, dispatch overhead, additional vehicles and insurance, and a marketing spend that must now fill three calendars instead of one. Fleets win on absolute dollars and on the founder's liberation from the injection chair, not on percentage. A hybrid with a physical location compresses further because rent is fixed and the location must be staffed regardless of bookings. Franchises compress further still, because royalty and marketing fund come off the top line.

The franchise arithmetic specifically. Franchise fees in this category commonly run into the low-to-mid six figures at the upper end, with royalties in the mid-to-high single digits of gross revenue plus a marketing fund contribution of a few percent. On $1.5 million of revenue, a combined ten-percent take is $150,000 annually — which is a fair price if the brand meaningfully lowers your customer acquisition cost and the compliance support keeps you out of a board proceeding, and a terrible price if you were going to build local demand organically anyway. Model it both ways against a realistic, not optimistic, organic acquisition curve.

Compounding pharmacy economics and risk. Your ingredients come from compounding pharmacies operating under one of two federal frameworks: 503A pharmacies compound patient-specific prescriptions, while 503B outsourcing facilities are FDA-registered and may produce office stock. This distinction, created by the Drug Quality and Security Act after the 2012 New England Compounding Center meningitis outbreak that killed dozens and sickened hundreds, is not a technicality — it determines whether you may legally hold inventory on your shelf versus dispense against a named patient's order. FDA has also tightened rules governing interstate distribution of 503A-compounded products, which pushes many multi-state operators toward 503B office stock or in-state 503A relationships.

The operational lesson is redundancy. Maintain relationships with two or three pharmacies, not one. FDA inspection findings and voluntary recalls periodically knock a supplier offline for weeks, and single-vendor operators discover this during the week they had four NAD+ appointments booked. Keep two to four weeks of rolling stock per SKU, track lots, rotate by expiration, refrigerate what requires it, and maintain a dispensing log that satisfies your state pharmacy board. Inventory carrying cost runs $4,000 to $12,000 for a starting solo operator, more at scale.

Labor cost, honestly. Nurse wages have risen substantially since 2020 across the entire US healthcare labor market — check current Bureau of Labor Statistics occupational data for your metro rather than any figure quoted in an article. Mobile IV competes for the same nurses as hospitals, travel agencies, aesthetics practices, and infusion centers, and it competes with a per-visit or hourly rate that has to clear what a hospital shift differential offers. Budget above your instinct.

Classification risk. Many operators default to 1099 contractor nurses. The IRS common-law test and, in states like California, the stricter ABC test, both scrutinize this arrangement hard when you control the schedule, the protocols, the pricing, and the branding — which you do, because your medical director's standing orders require it. Misclassification exposure includes back payroll taxes, workers' compensation premiums, unemployment insurance, and penalties. Many operators moved nurses to W-2 specifically because the scope-of-practice control they need is incompatible with contractor independence. Have counsel bless the structure rather than assuming.

Implementation sequencing from formation to first appointment

Expect two to six months from entity formation to first paid appointment, and twelve to twenty-four months to a mature route. Sequence matters, because several steps are hard-blocked by earlier ones — you cannot bind malpractice coverage without a documented physician relationship, and you cannot open a pharmacy account without an entity and a licensed prescriber.

Weeks one through four: legal foundation. Confirm your state's scope regime with counsel. Form the entity — an LLC in some states, a professional corporation or PLLC in states with corporate-practice-of-medicine restrictions, which is a determination counsel makes, not you. Obtain your EIN and state tax registrations. Verify your nursing license is current and unencumbered. Begin recruiting a collaborating physician or medical director; this takes longer than founders plan, and the search is materially easier if you approach physicians who already supervise aesthetic or wellness practices in your market.

Weeks four through eight: clinical and compliance scaffolding. Execute the collaborative practice agreement or medical director agreement. Draft standing orders covering every bag and injectable on your menu — not a generic template, but protocol-specific documents naming ingredients, doses, contraindications, and escalation criteria. Build per-SKU informed consent forms. Establish your valid physician examination workflow, whether through your medical director directly or a telehealth physician network. Write your adverse event protocol before you need it.

Weeks six through ten: insurance and vendors. Bind nurse professional liability, commercial auto with a business-use endorsement (a personal auto policy will not cover you carrying medical supplies to a paid appointment, and discovering this at claim time is catastrophic), general liability, cyber liability given the protected health information you handle, and workers' compensation if you have employees. Open accounts with two or three compounding pharmacies — expect them to verify your license, your prescriber relationship, and your entity registration. Order equipment and initial inventory.

Weeks eight through twelve: systems. Stand up HIPAA-compliant scheduling and charting, and execute a business associate agreement with every vendor that touches patient data — that includes your scheduling platform, your storage provider, and your email host if it carries anything identifiable. Configure payment processing. Build your intake questionnaire to capture medical history, current medications, allergies, pregnancy status, and any screening your specific menu requires. Set up your booking flow so a patient can go from ad click to confirmed appointment without a phone call, because the market has trained them to expect that.

Weeks ten through sixteen: demand. Local search presence and a Google Business Profile. Instagram, which remains the dominant discovery surface for this category. Paid search on high-intent local terms. Then the channel that actually separates surviving operators from failing ones: business-to-business relationships. Hotel concierge desks in tourism-heavy markets. Wedding and bachelorette planners. Corporate wellness coordinators. Endurance race organizers. Recovery-focused gyms and boxing studios. These relationships convert at rates paid social cannot approach, they arrive pre-trusted, and they book groups rather than individuals — a four-person bachelorette booking at a group rate outearns a solo appointment on the same drive time.

Concierge relationships typically involve a referral share, and hotels in premium markets expect meaningful percentages. Price for it rather than discovering the take rate after you have set your menu.

Ongoing: the compliance loop that keeps you licensed. Every visit generates a chart: intake, documented physician examination, per-SKU consent, pre-administration vitals, IV start details including gauge and site and attempts, an administration log recording drug, dose, lot, expiration, and times, post-administration vitals, and discharge instructions with an emergency contact. Your medical director reviews a sample monthly — ten to twenty percent is the commonly cited standard. Adverse events get logged, escalated to the physician promptly, and reported to your carrier when they involve emergency services. Annual HIPAA training per nurse. This documentation is not bureaucratic theater; it is the entire substance of your defense if a board complaint arrives, and board complaints in this category arrive from competitors and disgruntled patients alike.

On marketing claims. The FTC requires competent and reliable scientific evidence to substantiate health claims, and both FDA and FTC have issued warning letters to wellness IV operators over language promising immune boosting, hangover curing, or anti-aging outcomes. Major medical institutions have published skeptically about the evidence base for IV vitamin therapy in healthy populations. Whatever you believe about the clinical value, the regulatory reality is fixed: market hydration, convenience, comfort, and experience. Do not market disease treatment, prevention, or cure. Have counsel review your ad copy the same way you would have them review a contract.

Adjacent lessons worth stealing. The operators who scale cleanly borrow their operating discipline from home-services businesses rather than from clinics — route density, drive-time minimization, dispatch software, technician utilization tracking, and per-job margin reporting are all solved problems in HVAC and plumbing, and the same RevOps instincts apply directly: define your funnel stages, instrument conversion between them, and know your cost per acquired customer by channel rather than in aggregate. A mobile IV operator who can state their blended acquisition cost, their ninety-day repeat rate, their membership penetration, and their revenue per route-day is running a real business. One who cannot is running a nursing job with extra paperwork.

What breaks these clinics, and what the survivors do differently

The failure modes are consistent enough to enumerate, and almost none of them are capital-related.

Scope and supervision drift. An operator launches with a clean collaborative practice agreement, then quietly expands the menu into territory the standing orders never covered — aesthetic injectables, weight-loss pharmaceuticals, ketamine adjuncts. Each addition carries its own scope, licensing, and sometimes DEA implications. Controlled substances require registration and secure storage that most mobile setups do not have. Expand the menu only with counsel and your medical director signing off in writing, protocol by protocol.

Supply single-threading. Covered above, but it kills more launches than it should. One pharmacy relationship is one FDA inspection away from a dark month.

Acquisition cost blindness. Paid social costs have risen sharply across every consumer category since 2020, and wellness advertising carries additional platform restrictions on health claims. Operators who build entirely on paid acquisition watch margin evaporate as costs climb. The durable book is B2B contracts plus memberships plus referrals — recurring revenue at near-zero marginal acquisition cost. Push toward a meaningful membership penetration and treat every satisfied patient as a referral source with an explicit incentive.

Underpricing the drive. A $185 appointment forty minutes away is a worse business than a $185 appointment eight minutes away, and many operators never separate the two in their reporting. Set minimum tickets by zone, charge travel premiums beyond a radius, batch appointments geographically, and favor group bookings that amortize one drive across four patients.

Insurance gaps. Personal auto policies exclude business use. Nurse malpractice policies increasingly require documented supervision relationships as a condition of coverage. A claim discovered to fall outside coverage is the fastest path from profitable practice to personal bankruptcy in this entire model.

Ignoring the demand-side skepticism. The clinical evidence for IV vitamin therapy in healthy people is contested by major medical institutions, and organized medicine has actively challenged wellness IV scope expansion. That is not a reason to avoid the business — the demand is real and cash-paying — but it is a reason to build a practice that is clinically conservative, documentation-heavy, and marketed on convenience and experience rather than on medical outcomes. The operators who survive the next regulatory tightening will be the ones whose charts and ad copy already read like they expected the scrutiny.

What survivors do. They know their numbers weekly, not quarterly. They keep two pharmacies warm. They put the medical director on a real retainer with real chart review rather than a nominal signature. They build B2B before they need it. They say no to menu items that outrun their standing orders. And they treat the compliance stack as the product moat it actually is, because in a category where anyone with a nursing license and a car can enter, the defensible position is being the operator who is still standing after the board sends its next letter.

Related questions

Can I start a mobile IV clinic without being a nurse?

Yes, but you must contract or employ licensed clinical staff before generating revenue, which raises your capital floor considerably. Some states also restrict non-clinician ownership of medical entities. Franchise and platform models suit non-clinical founders better because they supply the clinical infrastructure.

How long until a mobile IV clinic is profitable?

Most solo operators reach cash-flow positive between months four and ten, with a mature stabilized route taking twelve to twenty-four months. Profitability arrives faster in tourism-heavy markets with hotel and event channels, slower in markets requiring an expensive medical director arrangement.

Do I need a physical location?

No — location-free operation is the model's core cost advantage. A physical drip bar adds walk-in volume, retail sales, and a trust signal, but converts your low fixed-cost structure into a rent-carrying one. Add it only after mobile demand consistently exceeds your route capacity.

Can I bill insurance for IV therapy?

Generally no. Wellness IV hydration is cash-pay. Medically necessary hydration with a qualifying diagnosis can occasionally be billed, but building around insurance reimbursement means you are actually building an infusion center, which is a different regulatory and capital model entirely.

What is the biggest hidden cost?

Clinical supervision. Medical director retainers, chart review time, valid physician examination fees, and the legal work maintaining your standing orders compound monthly and are the line item first-time founders most consistently omit from their models.

FAQ

What does it realistically cost to start a mobile IV therapy clinic?

A solo nurse-owned launch typically lands between $45,000 and $185,000 covering entity formation, legal work, medical director retainer, starting inventory, IV equipment, vehicle expenses, the full insurance stack, software, and several months of marketing. Two-to-three-nurse fleets run $185,000 to $485,000. A drip-bar hybrid with a physical location runs $285,000 to $685,000. Franchise fees sit on top of build-out costs. Budget above your estimate — legal and supervision costs are where first-time founders under-provision most.

Which states are easiest to operate in?

States operating under a collaborative practice agreement framework — Florida, Texas, Arizona, Colorado, Nevada, Georgia, Tennessee, and North Carolina are commonly cited — generally offer clearer, cheaper paths because a registered nurse can administer under standing orders with periodic physician review. California, New York, New Jersey, Massachusetts, Illinois, and Pennsylvania typically demand a formal medical director relationship with documented patient examination, raising both cost and complexity. Verify current requirements with counsel; board interpretations shift.

Where do the IV bags and ingredients come from?

From compounding pharmacies operating under FDA frameworks: 503A pharmacies compound patient-specific prescriptions, and 503B outsourcing facilities are FDA-registered and may supply office stock. Which one you can use depends on your state's rules and whether you hold inventory or dispense per patient. Maintain relationships with two or three suppliers — inspection findings and recalls periodically take a pharmacy offline for weeks, and single-source operators lose those weeks entirely.

How do I market without triggering FTC or FDA problems?

Market hydration, convenience, comfort, and the in-home experience. Do not claim your service treats, prevents, or cures any condition, boosts immunity, or reverses aging. The FTC requires competent and reliable scientific evidence to substantiate health claims, and both agencies have sent warning letters to wellness IV operators over exactly this language. Have counsel review your website, ad copy, and social captions, and train any contractor writing content for you.

What insurance does a mobile IV business actually need?

Nurse professional liability for every clinician, commercial auto with a business-use endorsement covering the vehicle carrying medical supplies, general liability, cyber liability given the protected health information you handle, and workers' compensation if you employ staff. Carriers have tightened underwriting and increasingly condition coverage on documented supervision relationships — a collaborative practice agreement or medical director contract, standing orders, and examination workflow. Coverage gaps discovered at claim time are the most expensive mistake available in this model.

How many patients per day can one nurse realistically serve?

Four to eight in a well-routed metro day, which is why drive time is the real constraint rather than capital or inventory. Longer infusions like NAD+ consume one to four hours each and cut daily capacity sharply. Route density, geographic batching, group bookings, and intramuscular add-ons sold to patients you already drove to are the four levers that move revenue per route-day without adding hours.

Sources

1. FDA — Human Drug Compounding (503A and 503B frameworks): https://www.fda.gov/drugs/human-drug-compounding
2. FDA — Warning Letters database: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters
3. FTC — Health Products Compliance Guidance: https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
4. CDC — Fungal Meningitis Outbreak Associated with Injection of Contaminated Steroid (NECC, 2012): https://www.cdc.gov/hai/outbreaks/meningitis.html
5. HHS Office for Civil Rights — HIPAA Privacy, Security, and Breach Notification Rules: https://www.hhs.gov/hipaa
6. Bureau of Labor Statistics — Occupational Employment and Wage Statistics: https://www.bls.gov/oes/
7. IRS — Independent Contractor (Self-Employed) or Employee?: https://www.irs.gov/businesses/small-businesses-self-employed/independent-contractor-self-employed-or-employee
8. California Department of Industrial Relations — Independent Contractor / AB5 ABC test FAQ: https://www.dir.ca.gov/dlse/faq_independentcontractor.htm
9. DEA Diversion Control Division — Registration requirements: https://www.deadiversion.usdoj.gov/
10. Harvard Health Publishing — commentary on IV vitamin therapy: https://www.health.harvard.edu

Related on PULSE

• [How do you start an IV therapy clinic business in 2027?](/knowledge/q2087)
• [How do I budget an IV therapy or wellness clinic buildout?](/knowledge/q13786)
• [How do you start a physical therapy practice in 2027?](/knowledge/q9687)
• [How do I budget a physical therapy clinic buildout?](/knowledge/q13822)
• [What service fees should a physical therapy clinic charge?](/knowledge/q16166)
• [How many sales reps do I need to hire for my physical therapy clinic group?](/knowledge/q15956)